Perspective Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	2016 - 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Revenue	1.45	1.43	5.42	-	10.05	Upgrade
Revenue Growth (YoY)	1.40%	-73.52%	-	-	3.85%	Upgrade
Cost of Revenue	39.43	20.34	3.05	-	4.93	Upgrade
Gross Profit	-37.98	-18.91	2.37	-	5.12	Upgrade
Selling, General & Admin	26.61	21.06	9.35	5.57	7.13	Upgrade
Research & Development	2.21	0.97	1.81	0.85	1.43	Upgrade
Operating Expenses	28.82	22.03	11.17	6.42	8.56	Upgrade
Operating Income	-66.8	-40.94	-8.8	-6.42	-3.44	Upgrade
Interest Expense	-0.05	-0.08	-	-	-	Upgrade
Interest & Investment Income	10.52	0.93	0.62	0.12	0.06	Upgrade
Earnings From Equity Investments	-0.01	-0.02	-	-	-	Upgrade
EBT Excluding Unusual Items	-56.34	-40.11	-8.18	-6.3	-3.38	Upgrade
Impairment of Goodwill	-24.06	-	-	-	-	Upgrade
Gain (Loss) on Sale of Assets	-0.03	-	-0.31	-	-0.01	Upgrade
Pretax Income	-80.43	-40.11	-8.49	-6.3	-3.39	Upgrade
Income Tax Expense	-2.1	-2.65	-	-	-	Upgrade
Earnings From Continuing Operations	-78.33	-37.46	-8.49	-6.3	-3.39	Upgrade
Earnings From Discontinued Operations	-0.95	-9.05	-2.28	-0.97	-	Upgrade
Net Income	-79.28	-46.51	-10.76	-7.27	-3.39	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	0	Upgrade
Net Income to Common	-79.28	-46.51	-10.76	-7.27	-3.39	Upgrade
Shares Outstanding (Basic)	64	27	14	14	10	Upgrade
Shares Outstanding (Diluted)	64	27	14	14	10	Upgrade
Shares Change (YoY)	140.72%	88.38%	0.06%	36.73%	53.61%	Upgrade
EPS (Basic)	-1.23	-1.74	-0.76	-0.51	-0.33	Upgrade
EPS (Diluted)	-1.23	-1.74	-0.76	-0.51	-0.33	Upgrade
Free Cash Flow	-72.71	-37.99	-10.68	-7.98	-3.22	Upgrade
Free Cash Flow Per Share	-1.13	-1.42	-0.75	-0.56	-0.31	Upgrade
Gross Margin	-	-	43.71%	-	50.94%	Upgrade
Operating Margin	-4594.02%	-2855.02%	-162.47%	-	-34.19%	Upgrade
Profit Margin	-5452.48%	-3243.24%	-198.71%	-	-33.72%	Upgrade
Free Cash Flow Margin	-5000.55%	-2648.88%	-197.28%	-	-32.01%	Upgrade
EBITDA	-64.5	-40.23	-8.48	-6.14	-3.23	Upgrade
EBITDA Margin	-	-	-156.56%	-	-32.10%	Upgrade
D&A For EBITDA	2.3	0.71	0.32	0.28	0.21	Upgrade
EBIT	-66.8	-40.94	-8.8	-6.42	-3.44	Upgrade
EBIT Margin	-	-	-162.47%	-	-34.19%	Upgrade
Revenue as Reported	-	-	5.42	-	-	Upgrade

Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q